Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox Gastaut Syndrome
In brief
The objective of this study is to assess the safety, tolerability, efficacy, and pharmacokinetics of adjunctive therapy of LP352 in adults and adolescents with developmental and epileptic encephalopathies.
Key facts
- Study ID
- NCT05364021
- Run by
- Longboard Pharmaceuticals
- People needed
- 52
- Starts
- 2022-03-03
- Expected to finish
- 2023-11-20
- Last updated by the study team
- 2024-11-08
Who can join
Age: 12 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arizona - Health Sciences Center — Tucson, Arizona, United States
- Arkansas Children's Hospital — Little Rock, Arkansas, United States
- Rancho Los Amigos National Rehabilitation Center (RLANRC) — Downey, California, United States
- Children's Hospital of Orange County — Orange, California, United States
- University of California San Francisco — San Francisco, California, United States
- Northwest Florida Clinical Research Group — Gulf Breeze, Florida, United States
- University of Miami — Miami, Florida, United States
- Advent Health Orlando — Orlando, Florida, United States
- Research Institute of Orlando — Orlando, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Hawaii Pacific Neuroscience — Honolulu, Hawaii, United States
- Consultants in Epilepsy and Neurology — Boise, Idaho, United States
- Northwestern University Feinberg School of Medicine — Chicago, Illinois, United States
- Mid-Atlantic Epilepsy and Sleep Center — Bethesda, Maryland, United States
- Spectrum Health — Grand Rapids, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Boston Children's Health Physicians LLP — Hawthorne, New York, United States
- New York University Langone Hospital - Long Island — Mineola, New York, United States
- Northwell Health — New York, New York, United States
- Northeast Regional Epilepsy Group — Staten Island, New York, United States
- OnSite Clinical Solutions LLC — Charlotte, North Carolina, United States
- Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States
- University Hospitals Cleveland Medical Center — Cleveland, Ohio, United States
- Providence Neurological Specialties-East — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.